TP53 and diabetes mellitus: This limitation is particularly evident in two aspects: 1) Mutation analysis: Although we stratified somatic mutations by risk score and observed significantly higher mutation frequencies of genes such as TP53 in the high-risk group, we did not explore whether these mutation differences are directly related to diabetes status.